Artificial heart maker Carmat suspends implants due to quality issueArtificial Hearts, Business, Implants, Medical DevicesCarmat on December 3 said the French medical device company suspended implants of the Aeson artificial hearts following a quality issue affecting some of its prostheses. Read more December 3, 2021/by Reuters Health https://www.pharmalive.com/wp-content/uploads/2021/12/Artificial-heart-maker-Carmat-suspends-implants-due-to-quality-issue-Reuters-12-3-21.jpg 503 960 Reuters Health https://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.png Reuters Health2021-12-03 14:40:002021-12-03 17:38:12Artificial heart maker Carmat suspends implants due to quality issue